The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 476,295 | 453,614 | SH | SOLE | 453,614 | 0 | 0 | |||
ALLAKOS INC | COM | 01671P100 | 1,214,315 | 444,804 | SH | SOLE | 444,804 | 0 | 0 | |||
ARGENX SE | SPONSORED ADR | 04016X101 | 26,630,100 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | |||
ATYR PHARMA INC | COM NEW | 002120202 | 2,120,011 | 1,503,554 | SH | SOLE | 1,503,554 | 0 | 0 | |||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 4,589,000 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | |||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 12,363,988 | 155,346 | SH | SOLE | 155,346 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 19,202,700 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | |||
DISC MEDICINE INC | COM | 254604101 | 577,600 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 361,020 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | |||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 1,704,881 | 293,945 | SH | SOLE | 293,945 | 0 | 0 | |||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 10,067,200 | 880,000 | SH | SOLE | 880,000 | 0 | 0 | |||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 5,720,000 | 500,000 | SH | Call | SOLE | 0 | 0 | 500,000 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 6,897,614 | 233,659 | SH | SOLE | 233,659 | 0 | 0 | |||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 3,281,742 | 359,446 | SH | SOLE | 359,446 | 0 | 0 | |||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 6,119,008 | 266,856 | SH | SOLE | 266,856 | 0 | 0 | |||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 33,558,100 | 730,000 | SH | SOLE | 730,000 | 0 | 0 | |||
SPDR BIOTECH ETF TR | UNIT | 78464A870 | 16,072,200 | 180,000 | SH | Put | SOLE | 0 | 0 | 180,000 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 12,410,000 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | |||
TREVI THERAPEUTICS INC | COM | 89532M101 | 1,731,703 | 1,292,316 | SH | SOLE | 1,292,316 | 0 | 0 |